Arbutus Biopharma (ABUS) EBIT Margin (QoQ) (2013 - 2026)
Arbutus Biopharma (ABUS) EBIT Margin (QoQ) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Arbutus Biopharma |
882.62 Mn |
882.62 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
59,763.00 |
| Dec 31, 2025 |
113,353.00 |
| Sep 30, 2025 |
-165,072.00 |
| Jun 30, 2025 |
147,072.00 |
| Mar 31, 2025 |
-57,166.00 |
| Dec 31, 2024 |
71,600.00 |
| Sep 30, 2024 |
-35,073.00 |
| Jun 30, 2024 |
1,344.00 |
| Mar 31, 2024 |
-29,668.00 |
| Dec 31, 2023 |
-50,441.00 |
| Sep 30, 2023 |
-6,753.00 |
| Jun 30, 2023 |
-13,489.00 |
| Mar 31, 2023 |
10,088.00 |
| Dec 31, 2022 |
-6,204.00 |
| Sep 30, 2022 |
-20,017.00 |
| Jun 30, 2022 |
-1,185.00 |
| Mar 31, 2022 |
56,143.00 |
| Dec 31, 2021 |
-9,752.00 |
| Sep 30, 2021 |
24,929.00 |
| Jun 30, 2021 |
-5,855.00 |
